These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 21343930)

  • 41. Effect of organized mammography screening on breast cancer mortality: A population-based cohort study in Norway.
    Møller MH; Lousdal ML; Kristiansen IS; Støvring H
    Int J Cancer; 2019 Feb; 144(4):697-706. PubMed ID: 30144028
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The benefits and harms of breast cancer screening: an independent review.
    Independent UK Panel on Breast Cancer Screening
    Lancet; 2012 Nov; 380(9855):1778-86. PubMed ID: 23117178
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Breast cancer deaths averted over 3 decades.
    Hendrick RE; Baker JA; Helvie MA
    Cancer; 2019 May; 125(9):1482-1488. PubMed ID: 30740647
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Breast-cancer mortality in screened versus unscreened women: Long-term results from a population-based study in Queensland, Australia.
    Dunn N; Youl P; Moore J; Harden H; Walpole E; Evans E; Taylor K; Philpot S; Furnival C
    J Med Screen; 2021 Jun; 28(2):193-199. PubMed ID: 32842857
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Mammographic screening after the age of 65 years: evidence for a reduction in breast cancer mortality.
    Van Dijck JA; Verbeek AL; Beex LV; Hendriks JH; Holland R; Mravunac M; Straatman H; Werre JM
    Int J Cancer; 1996 Jun; 66(6):727-31. PubMed ID: 8647640
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Breast cancer screening: are we seeing the benefit?
    Puliti D; Zappa M
    BMC Med; 2012 Sep; 10():106. PubMed ID: 22995098
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effect of implementing digital breast tomosynthesis (DBT) instead of mammography on population screening outcomes including interval cancer rates: Results of the Trento DBT pilot evaluation.
    Bernardi D; Gentilini MA; De Nisi M; Pellegrini M; Fantò C; Valentini M; Sabatino V; Luparia A; Houssami N
    Breast; 2020 Apr; 50():135-140. PubMed ID: 31607526
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Breast cancer mortality in participants of the Norwegian Breast Cancer Screening Program.
    Hofvind S; Ursin G; Tretli S; Sebuødegård S; Møller B
    Cancer; 2013 Sep; 119(17):3106-12. PubMed ID: 23720226
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Reduction in advanced breast cancer after introduction of a mammography screening program in Tyrol/Austria.
    Oberaigner W; Geiger-Gritsch S; Edlinger M; Daniaux M; Knapp R; Hubalek M; Siebert U; Marth C; Buchberger W
    Breast; 2017 Jun; 33():178-182. PubMed ID: 28419909
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Evaluation of mammographic surveillance services in women aged 40-49 years with a moderate family history of breast cancer: a single-arm cohort study.
    Duffy SW; Mackay J; Thomas S; Anderson E; Chen TH; Ellis I; Evans G; Fielder H; Fox R; Gui G; Macmillan D; Moss S; Rogers C; Sibbering M; Wallis M; Warren R; Watson E; Whynes D; Allgood P; Caunt J
    Health Technol Assess; 2013 Mar; 17(11):vii-xiv, 1-95. PubMed ID: 23489892
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Pan-Canadian study of mammography screening and mortality from breast cancer.
    Coldman A; Phillips N; Wilson C; Decker K; Chiarelli AM; Brisson J; Zhang B; Payne J; Doyle G; Ahmad R
    J Natl Cancer Inst; 2014 Nov; 106(11):. PubMed ID: 25274578
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Results of intermediate measures from a population-based, randomized trial of mammographic screening prevalence and detection of breast carcinoma among Asian women: the Singapore Breast Screening Project.
    Ng EH; Ng FC; Tan PH; Low SC; Chiang G; Tan KP; Seow A; Emmanuel S; Tan CH; Ho GH; Ng LT; Wilde CC
    Cancer; 1998 Apr; 82(8):1521-8. PubMed ID: 9554530
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Service screening with mammography of women aged 50-69 years in Sweden: effects on mortality from breast cancer.
    Jonsson H; Nyström L; Törnberg S; Lenner P
    J Med Screen; 2001; 8(3):152-60. PubMed ID: 11678556
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Breast cancer mortality in mammographic screening in Europe: a review of incidence-based mortality studies.
    Njor S; Nyström L; Moss S; Paci E; Broeders M; Segnan N; Lynge E;
    J Med Screen; 2012; 19 Suppl 1():33-41. PubMed ID: 22972809
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Twenty five year follow-up for breast cancer incidence and mortality of the Canadian National Breast Screening Study: randomised screening trial.
    Miller AB; Wall C; Baines CJ; Sun P; To T; Narod SA
    BMJ; 2014 Feb; 348():g366. PubMed ID: 24519768
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Tailored Breast Screening Trial (TBST)].
    Paci E; Mantellini P; Giorgi Rossi P; Falini P; Puliti D;
    Epidemiol Prev; 2013; 37(4-5):317-27. PubMed ID: 24293498
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Breast cancer screening: controversy of impact.
    Berry DA
    Breast; 2013 Aug; 22 Suppl 2(0 2):S73-6. PubMed ID: 24074796
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Case-control Studies on the Effectiveness of Breast Cancer Screening: Insights from the UK Age Trial.
    van der Waal D; Broeders MJ; Verbeek AL; Duffy SW; Moss SM
    Epidemiology; 2015 Jul; 26(4):590-6. PubMed ID: 25767987
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Mammographic surveillance in women younger than 50 years who have a family history of breast cancer: tumour characteristics and projected effect on mortality in the prospective, single-arm, FH01 study.
    FH01 collaborative teams
    Lancet Oncol; 2010 Dec; 11(12):1127-34. PubMed ID: 21093374
    [TBL] [Abstract][Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.